These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
572 related articles for article (PubMed ID: 25824780)
1. XIAP associated factor 1 (XAF1) represses expression of X-linked inhibitor of apoptosis protein (XIAP) and regulates invasion, cell cycle, apoptosis, and cisplatin sensitivity of ovarian carcinoma cells. Zhao WJ; Deng BY; Wang XM; Miao Y; Wang JN Asian Pac J Cancer Prev; 2015; 16(6):2453-8. PubMed ID: 25824780 [TBL] [Abstract][Full Text] [Related]
2. Association of expression of XIAP-associated factor 1 (XAF1) with clinicopathologic factors, overall survival, microvessel density and cisplatin-resistance in ovarian cancer. Wang Y; Mao H; Hao Q; Wang Y; Yang Y; Shen L; Huang S; Liu P Regul Pept; 2012 Oct; 178(1-3):36-42. PubMed ID: 22759793 [TBL] [Abstract][Full Text] [Related]
3. PD98059 impairs the cisplatin-resistance of ovarian cancer cells by suppressing ERK pathway and epithelial mesenchymal transition process. Hou L; Hou X; Wang L; Li Z; Xin B; Chen J; Gao X; Mu H Cancer Biomark; 2017 Dec; 21(1):187-194. PubMed ID: 29103028 [TBL] [Abstract][Full Text] [Related]
4. Effect of diallyl trisulfide on human ovarian cancer SKOV- 3/DDP cell apoptosis. Wan HF; Yu LH; Wu JL; Tu S; Zhu WF; Zhang XL; Wan FS Asian Pac J Cancer Prev; 2013; 14(12):7197-201. PubMed ID: 24460275 [TBL] [Abstract][Full Text] [Related]
5. Synergistic suppression effect on tumor growth of hepatocellular carcinoma by combining oncolytic adenovirus carrying XAF1 with cisplatin. Ma B; Wang Y; Zhou X; Huang P; Zhang R; Liu T; Cui C; Liu X; Wang Y J Cancer Res Clin Oncol; 2015 Mar; 141(3):419-29. PubMed ID: 25240826 [TBL] [Abstract][Full Text] [Related]
6. Role of X‑linked inhibitor of apoptosis‑associated factor‑1 in vasculogenic mimicry in ovarian cancer. Wang Y; Liu P; Wang X; Mao H Mol Med Rep; 2017 Jul; 16(1):325-330. PubMed ID: 28534973 [TBL] [Abstract][Full Text] [Related]
7. Soluble CD40 ligands sensitize the epithelial ovarian cancer cells to cisplatin treatment. Qin L; Qiu H; Zhang M; Zhang F; Yang H; Yang L; Jia L; Qin K; Jia L; Dou X; Cheng L; Sang M; Zhang C; Shan B; Zhang Z Biomed Pharmacother; 2016 Apr; 79():166-75. PubMed ID: 27044825 [TBL] [Abstract][Full Text] [Related]
8. Association of Sp1 and survivin in epithelial ovarian cancer: Sp1 inhibitor and cisplatin, a novel combination for inhibiting epithelial ovarian cancer cell proliferation. Sankpal UT; Ingersoll SB; Ahmad S; Holloway RW; Bhat VB; Simecka JW; Daniel L; Kariali E; Vishwanatha JK; Basha R Tumour Biol; 2016 Oct; 37(10):14259-14269. PubMed ID: 27581819 [TBL] [Abstract][Full Text] [Related]
9. Noscapine Increases the Sensitivity of Drug-Resistant Ovarian Cancer Cell Line SKOV3/DDP to Cisplatin by Regulating Cell Cycle and Activating Apoptotic Pathways. Shen W; Liang B; Yin J; Li X; Cheng J Cell Biochem Biophys; 2015 May; 72(1):203-13. PubMed ID: 25510462 [TBL] [Abstract][Full Text] [Related]
10. Impact of X-linked inhibitor of apoptosis protein on survival of nasopharyngeal carcinoma patients following radiotherapy. Ren M; Wang Z; Gao G; Gu X; Wu L; Chen L Tumour Biol; 2016 Sep; 37(9):11825-11833. PubMed ID: 27048285 [TBL] [Abstract][Full Text] [Related]
11. Downregulation of MACC1 expression enhances cisplatin sensitivity in SKOV-3/DDP cells. Chen ZM; Shi HR; Li X; Deng YX; Zhang RT Genet Mol Res; 2015 Dec; 14(4):17134-44. PubMed ID: 26681060 [TBL] [Abstract][Full Text] [Related]
12. Effect of autophagy-related beclin1 on sensitivity of cisplatin-resistant ovarian cancer cells to chemotherapeutic agents. Sun Y; Liu JH; Jin L; Sui YX; Han LL; Huang Y Asian Pac J Cancer Prev; 2015; 16(7):2785-91. PubMed ID: 25854363 [TBL] [Abstract][Full Text] [Related]
13. Experimental study on inhibition effects of the XAF1 gene against lung cancer cell proliferation. Yang WT; Chen DL; Zhang FQ; Xia YC; Zhu RY; Zhou DS; Chen YB Asian Pac J Cancer Prev; 2014; 15(18):7825-9. PubMed ID: 25292071 [TBL] [Abstract][Full Text] [Related]
14. XIAP gene downregulation by small interfering RNA inhibits proliferation, induces apoptosis, and reverses the cisplatin resistance of ovarian carcinoma. Ma JJ; Chen BL; Xin XY Eur J Obstet Gynecol Reprod Biol; 2009 Oct; 146(2):222-6. PubMed ID: 19758744 [TBL] [Abstract][Full Text] [Related]
15. [Inhibitory effects of survivin antisense oligonucleotide on drug-resistant human ovarian cancer cell COC1/DDP]. Ruan F; Xie XK; Liu SY Ai Zheng; 2004 Aug; 23(8):896-9. PubMed ID: 15301710 [TBL] [Abstract][Full Text] [Related]
16. Downregulation of miR-130a contributes to cisplatin resistance in ovarian cancer cells by targeting X-linked inhibitor of apoptosis (XIAP) directly. Zhang X; Huang L; Zhao Y; Tan W Acta Biochim Biophys Sin (Shanghai); 2013 Dec; 45(12):995-1001. PubMed ID: 24145606 [TBL] [Abstract][Full Text] [Related]
17. siRNA silencing EZH2 reverses cisplatin-resistance of human non-small cell lung and gastric cancer cells. Zhou W; Wang J; Man WY; Zhang QW; Xu WG Asian Pac J Cancer Prev; 2015; 16(6):2425-30. PubMed ID: 25824776 [TBL] [Abstract][Full Text] [Related]
18. MicroRNA-155 promotes apoptosis in SKOV3, A2780, and primary cultured ovarian cancer cells. Chen W; Huang L; Hao C; Zeng W; Luo X; Li X; Zhou L; Jiang S; Chen Z; He Y Tumour Biol; 2016 Jul; 37(7):9289-99. PubMed ID: 26779627 [TBL] [Abstract][Full Text] [Related]
19. miR-874-3p mitigates cisplatin resistance through modulating NF-κB/inhibitor of apoptosis protein signaling pathway in epithelial ovarian cancer cells. Wang Y; Yan C; Qi J; Liu C; Yu J; Wang H Mol Cell Biochem; 2022 Jan; 477(1):307-317. PubMed ID: 34716858 [TBL] [Abstract][Full Text] [Related]
20. [Establishment and biological characteristics of a platinum-resistance nude mouse model in epithelial ovarian cancer]. Shi L; Yu H; Zhang W; Li L; Wang Q Zhonghua Fu Chan Ke Za Zhi; 2014 Jul; 49(7):523-30. PubMed ID: 25327735 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]